<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <mixed-citation publication-type="other">Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:1–10. 10.1016/j.cell.2020.02.052. [Epub ahead of print]</mixed-citation>
</ref>
